Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEPHF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $108,597
Award facts
- Contract value 100% obligated
- $108,597.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $108,597.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 7, 2026, with an ultimate completion date of January 12, 2026, carries no set-aside designation and represents DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The award funds the delivery of pharmaceutical products and medical consumables to support Department of Defense healthcare operations.
This delivery order operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded November 13, 2025, that runs through December 31, 2036. The PPV-G GEN V is part of a broader $30.3 billion DLA acquisition strategy designed to establish multiple regional prime vendor contractors supplying branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's demonstrated performance delivering specialized pharmaceutical products across multiple therapeutic categories positions the company as a critical supplier within the federal military medical system's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEPHF?
SPE2DU26FEPHF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DU26FEPHF worth?
The government has obligated $108,597 on SPE2DU26FEPHF.
Is contract SPE2DU26FEPHF an order under another contract?
Yes. SPE2DU26FEPHF is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FEPHF competed?
The extent of competition for SPE2DU26FEPHF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award